VEA
RMD icon

Virtus ETF Advisers’s ResMed RMD Stock Holding History

Virtus ETF Advisers’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-31
Closed -$6.96K – 564
2026
Q1 		$6.96K Hold
31
– – ﹤0.01% 463
2025
Q4 		$7.47K Hold
31
– – ﹤0.01% 460
2025
Q3 		$8.49K Sell
31
-269
-90% -$73.5K ﹤0.01% 434
2025
Q2 		$77.4K Hold
300
– – 0.05% 329
2025
Q1 		$67.2K Sell
300
-4,361
-94% -$1.02M 0.04% 327
2024
Q4 		$1.07M Buy
+4,661
New +$1.12M 0.44% 109
2023
Q3 		– Sell
-3,441
Closed -$752K – 473
2023
Q2 		$752K Buy
+3,441
New +$767K 0.45% 87
2023
Q1 		– Sell
-3,473
Closed -$723K – 480
2022
Q4 		$723K Buy
+3,473
New +$763K 0.38% 114
2022
Q3 		– Sell
-3,147
Closed -$660K – 466
2022
Q2 		$660K Buy
+3,147
New +$670K 0.24% 154

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Virtus ETF Advisers's RMD Position: Q2 2026 in Review

Virtus ETF Advisers sold out of ResMed (RMD) in Q2 2026, closing a stake of 31 shares — an estimated $6.96K sold.

Virtus ETF Advisers first reported a position in RMD in Q2 2022 and held it in 9 quarters. The position peaked at $1.07M in Q4 2024. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Virtus ETF Advisers reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Virtus ETF Advisers sold 31 ResMed shares in Q2 2026, an estimated $6.96K.
  • Virtus ETF Advisers first reported a position in ResMed in Q2 2022 and held it in 9 quarters.
  • Virtus ETF Advisers's ResMed position peaked at $1.07M in Q4 2024.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Virtus ETF Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.